FOR RESEARCH PURPOSE ONLY
REDUXIN® (Sibutramine, Reductil, Meridia, Siredia, Sibutrex) is used to treat obesity. It reduces weight due to its potent actions: it reduces appetite, suppresses the feeling of hunger, thus reducing the amount of consumed food. Besides, Reduxin stimulates the body to consume more energy and use fat tissues as a source of energy. The key point is that Reduxin gradually decreases body weight - 0,5 kg per week. Taking Reduxin changes a personХs eating habits making him eat less food, which leads to the long-term maintenance of achieved results. Please consult your doctor and note the side effects before buying this product.
- Treat Alimentary Obesity with a Body Mass Index of 30 kg/m2 or more.
- Reduce Alimentary Obesity with a Body Mass Index of 27 kg/m2 or more.
- Treat Eating Disorders, such as Anorexia Nervosa or Bulimia Nervosa.
GUARANTEE & EXPIRY DATE
100% Original from the Russian Promomed.
All packs are air tight sealed and expire up to 10.2024.
Reduxin contains the active substance - sibutramine - a prodrug which inhibits the reuptake of monoamines (norepinephrine and serotonin), thus increasing the level of neurotransmitters in the synapses. This stimulates the activity of central serotonin 5-HT-receptors and adrenergic receptors, which increases satiety and reduces the need for food. It also increases termoproduction. Sibutramine affects the brown adipose tissue, decreases amounts of triglycerides, total cholesterol, LDL cholesterol, and uric acid. Further read: https://en.wikipedia.org/wiki/Sibutramine
PACKAGING & DOSAGE
Reduxin comes in the form of capsules. Each capsule contains sibutramine hydrochloride monohydrate - 10mg or 15mg, microcrystalline cellulose 153.5mg
For oral administration. The capsule should be taken 1 time in the morning on an empty stomach or with meals.
Treatment should not last more than 3 months in patients who do not respond well enough to therapy, i.e. those who during the 3 months of treatment cannot achieve 5% weight loss of the initial starting weight. Treatment should not be continued if, in further therapy, after the body weight reduction is achieved, the patient again adds 3 kg or more in the body mass. The duration of treatment should not exceed 2 years, since there is no data on efficacy and safety for a longer period of sibutramine intake. Treatment Reduxin should be carried out in conjunction with diet and exercise under the supervision of a doctor who has a practical experience in the treatment of obesity.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications. Please consult your doctor and note the side effects before buying this product: https://en.wikipedia.org/wiki/Sibutramine
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Reduxin.